Abstract:OBJECTIVES(1) To investigate the levels of the serum soluble endothelial growth factor receptor-1 in women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. For more, to analyze the relativity between the levels of the serum soluble vascular growth factor receptor-1 and preeclampsia. (2) To detect the expression of the membrane-bound VEGFR-1 protein in the placenta tissue of the women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia, Then to analyze the relativity between the expression of the membrane-bound endothelial growth factor receptor-1 and preeclampsia.METHODS(1) The serum levels of sVEGFR-1 in 10 women with mild preeclampsia, 10 women with severe preeclampsia, 10 women with eclampsia, 10 women without preeclampsia were detected by the quantitative sandwich enzyme immunoassay technique. (2) Immunohistochemistry and quantitative analysis were used to detect membrane-bound VEGFR-1 contents and distribution in the placenta tissue.RESULTS(1) The results showed that the serum sVEGFR-1 levels of all preeclampsia groups were relatively higher than those of control group (P < 0.05) and that there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. (2) In placentas, the positive staining was detected predominantly in the membranes of villus syncytiotrophoblast cells, extravillous trophoblast cells, and villus endothelial cells. In fetal membranes, the positive staining was detected predominantly in amnionic endothelial cells. (3) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group. There were significant differences between membrane-bound VEGFR-1 contents of the mild preeclampsia,severe preeclampsia and eclampsia (P < 0.05). (4) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/ membrane-bound VEGFR-1) was relatively higher than that of control group (P < 0.05) and there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia (P < 0.05).CONCLUSIONS(1) The serum sVEGFR-1 levels of preeclampsia groups were relatively higher than those of control group, the VEGFR-1 may be related to preeclampsia. (2) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group, the membrane-bound VEGFR-1 may relate to preeclampsia. (3) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/membrane-bound VEGFR-1) was relatively higher than that of control group, the preeclampsia may contribute to VEGFR-1/ PLGF and sVEGFR-1/membrane-bound.

Relationship of Hypoxia-inducible Factor-1αand Endoglin Expression in Placenta and Soluble Endoglin in Serum in Preeclampsia

Angiotensin Receptor Agonistic Autoantibody-Mediated Tumor Necrosis Factor-Alpha Induction Contributes To Increased Soluble Endoglin Production In Preeclampsia

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Expression and clinical implication of endothelial glycoprotein,vascular endothelial growth factor and its receptor 1 in preeclampsia

Expression of Hypoxia-Inducible Factor Prolyl 4-Hydroxylase in Placentas of Normal Pregnant Women and Patients with Pre-Eclampsia

Placental Endoglin Expression in Women with Severe Preeclampsia

[The Relativity of Vascular Endothelium Growth Factor Receptor-1 and Preeclampsia].

Changes of Endoglin in Maternal Serum and Placenta in Hypertensive Disorder Complicating Pregnancy

Study on the expressions of PHD and HIF in placentas from normal pregnant women and patients with preeclampsia.

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

Relationship between alterations of soluble endoglin in maternal serum and pathogenesis of patients with preeclampsia

Expression of Endothelin-1 and Endothelial Nitric Oxide Synthase Gene in Placental Villus in Preeclampsia

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Declined placental PLAC1 expression is involved in preeclampsia.

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

Elevated Serum Levels of Interleukin-15 and Interleukin-16 in Preeclampsia.

Serum and Placenta Homogenate Level of Heme Oxygenase-1 and Carbon Monoxide in Patients with Preeclampsia.

Relationship Between Expressions of Á2-Hs-glycoprotein Gene Mrna and Protein in Placenta and Insulin Resistance in Preeclampsia Patients

The expressions and significances of VEGF and p53 in placenta of normal pregnancy and pre-eclampsia patients

Placental Expression of Lipoprotein Lipase and Endothelial Lipase in Women with Severe Preeclampsia